Usually when you see a report of a study or a trial that includes anything alternative, it appears in the alternative news. So imagine my surprise when I saw a head-to-head trial of the major arthritis pain reliever vs. an alternative in medical news today.
Diclofenac is sold in the U.S. as a range of names, including Pennsaid. Wikipedia lists well over fifty different names of medications, which gives some indication of how successful it is as an NSAID pain killer. Compared to Diclofenac, Trameel is sold in health food stores and is comparatively unknown. But the manufacturers believed that it could hold its own in “a randomized, controlled, multicenter trial comparing Traumeel® Ointment and Gel with 1% diclofenac gel for the treatment of acute ankle sprain. It included 449 physically active participants aged 18-40 years who had a mild to moderate ankle sprains.” (http://www.medicalnewstoday.com/releases/265546.php)
At the end of the trial, all three groups had mostly recovered, and with similar results. Hopefully, the next trials will be large-scale trials of arthritis sufferers.
- Study demonstrates homeopathic Traumeel as effective treatment option for musculoskeletal disorders (medicalnewstoday.com)
- Diclofenac on the Verge of Reclassification (pharmababble.wordpress.com)
- Ease arthritis pain safely (consumerreports.org)
- Spice Up Your Life and Stop Arthritis in its Tracks with Curcumin (wholesomeone.com)
- How DARE doctors blame us for addiction (after-cancer.info)
- Investigational submicron diclofenac reduces use of opioid rescue medication in post-surgical pain in a Phase 3 study (medicalnewstoday.com)
- Drug Class 14: NSAIDs (Selective and Non-Selective) and Paracetamol (medicine1journal.wordpress.com)